{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T17:07:46Z","timestamp":1652720866957},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1986,7,1]],"date-time":"1986-07-01T00:00:00Z","timestamp":520560000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[1986,7]]},"DOI":"10.1007\/bf00394941","type":"journal-article","created":{"date-parts":[[2004,11,8]],"date-time":"2004-11-08T14:54:48Z","timestamp":1099925688000},"page":"61-66","source":"Crossref","is-referenced-by-count":4,"title":["6-Mercaptopurine: high-dose 24-h infusions in goats"],"prefix":"10.1007","volume":"112","author":[{"given":"T. J.","family":"Schouten","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. A.","family":"De Abreu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. D. A. M.","family":"Schretlen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. M.","family":"van Baal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. B.","family":"van Leeuwen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. A. M.","family":"de Vaan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S0378-4347(00)80408-9","volume":"227","author":"RA Abreu De","year":"1982","unstructured":"Abreu RA De, Baal JM van, Schouten TJ, Schretlen EDAM, Bruyn CHMM de (1982) High-performance liquid chromatographic determination of plasma 6-mercaptopurine in clinically relevant concentrations. J Chromatogr 227:526?533","journal-title":"J Chromatogr"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0378-4347(00)85171-3","volume":"336","author":"JM Baal van","year":"1984","unstructured":"Baal JM van, Leeuwen MB van, Schouten TJ, Abreu RA De (1984) Sensitive high-performance liquid chromatographic determination of 6-mercaptopurine, 6-thioguanine, 6-mercaptopurine riboside and 6-thioguanosine in biological fluids. J Chromatogr 336:422?428","journal-title":"J Chromatogr"},{"key":"CR3","first-page":"35","volume":"6","author":"LW Brox","year":"1981","unstructured":"Brox LW, Birkett L, Belch A (1981) Clinical pharmacology of oral thioguanine in acute myelogenous leukemia. Cancer Chemother Pharmacol 6:35?38","journal-title":"Cancer Chemother Pharmacol"},{"key":"CR4","first-page":"373","volume":"7","author":"TL Ding","year":"1979","unstructured":"Ding TL, Benet LZ (1979) Comparative bioavailability and pharmacokinetic studies of azathioprine and 6-mercaptopurine in the Rhesus monkey. Drug Metab Dispos 7:373?377","journal-title":"Drug Metab Dispos"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1056\/NEJM197208102870609","volume":"287","author":"MJ Duttera","year":"1972","unstructured":"Duttera MJ, Carolla RL, Gallelli JF, Gullion DS, Keim DE, Henderson ES (1972) Hematuria and crystalluria after high-dose 6-mercaptopurine administration. N Engl J Med 287:292?294","journal-title":"N Engl J Med"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1172\/JCI111068","volume":"72","author":"ME King","year":"1983","unstructured":"King ME, Honeysett JM, Howell SB (1983) Regulation of de novo purine synthesis in human bone marrow mononuclear cells by hypoxanthine. J Clin Invest 72:965?970","journal-title":"J Clin Invest"},{"key":"CR7","first-page":"309","volume-title":"Cancer: comprehensive treatise, vol V","author":"GA LePage","year":"1977","unstructured":"LePage GA (1977) Purine antagonists. In: Becker FF (ed) Cancer: comprehensive treatise, vol V. Plenum Press, New York, pp 309?326"},{"key":"CR8","volume-title":"Methotrexate in the central nervous system prophylaxis of children with acute lymphoblastic leukemia","author":"RJJ Lippens","year":"1981","unstructured":"Lippens RJJ (1981) Methotrexate in the central nervous system prophylaxis of children with acute lymphoblastic leukemia. Thesis Catholic University of Nijmegen. Mefar, Beetsterzwaag, The Netherlands"},{"key":"CR9","first-page":"9","volume":"70","author":"WJ Mackillop","year":"1983","unstructured":"Mackillop WJ, Ciampi A, Till JE, Buick RN (1983) A stem cell model of human tumor growth: implications for tumor cell clonogenic assays. J Natl Cancer Inst 70:9?16","journal-title":"J Natl Cancer Inst"},{"key":"CR10","first-page":"475","volume":"67","author":"S Matsumura","year":"1983","unstructured":"Matsumura S, Hoshino T, Weizsaecker M, Deen DF (1983) Paradoxical behavior of 6-mercaptopurine as a cytotoxic agent: decreasing cell kill with increasing drug dose. Cancer Treat Rep 67:475?480","journal-title":"Cancer Treat Rep"},{"key":"CR11","first-page":"527","volume":"61","author":"LB Mellett","year":"1977","unstructured":"Mellett LB (1977) Physicochemical considerations and pharmacokinetic behavior in delivery of drugs to the central nervous system. Cancer Treat Rep 61:527?531","journal-title":"Cancer Treat Rep"},{"key":"CR12","first-page":"5","volume":"11","author":"PK Narang","year":"1983","unstructured":"Narang PK, Chatterji DC, O'Neill D, Poplack DG (1983) Pharmacokinetics of 6-mercaptopurine (6MP) in the monkey. I. Disposition from plasma and cerebrospinal fluid following i.v. bolus. Drug Metab Dispos 11:5?9","journal-title":"Drug Metab Dispos"},{"key":"CR13","first-page":"1889","volume":"34","author":"JA Nelson","year":"1974","unstructured":"Nelson JA, Cserr HF, Chu SH (1974) Distribution of 6-mercaptopurine ribonucleoside and other purine analogs to brain. Cancer Res 34:1889?1891","journal-title":"Cancer Res"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/978-3-642-65806-8_18","volume-title":"6-Thiopurines. Handbook of pharmacology, XXXVIII\/2, antineoplastic and immunosuppressive agents","author":"ARP Paterson","year":"1975","unstructured":"Paterson ARP, Tidd DM (1975) 6-Thiopurines. Handbook of pharmacology, XXXVIII\/2, antineoplastic and immunosuppressive agents. Springer, Berlin Heidelberg New York, pp 384?403"},{"key":"CR15","first-page":"277","volume":"51","author":"W Regelson","year":"1967","unstructured":"Regelson W, Holland JF, Gold GL, Lynch J, Olson KB, Horton J, Hall TC, Krant M, Colsky J, Miller SP, Owens A (1967) 6-Mercaptopurine (NSC-755) given intravenously at weekly intervals to patients with advanced cancer. Cancer Chemother Rep 51:277?282","journal-title":"Cancer Chemother Rep"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/030089168306900106","volume":"69","author":"HTh Rupniak","year":"1983","unstructured":"Rupniak HTh, Dennis LY, Hill BT (1983) An intercomparison of in vitro assays for assessing cytotoxicity after a 24 h exposure to anticancer drugs. Tumori 69:37?42","journal-title":"Tumori"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0006-2952(79)90114-X","volume":"28","author":"EM Scholar","year":"1979","unstructured":"Scholar EM, Calabresi P (1979) Increased activity of alkaline phosphatase in leukemic cells from patients resistant to thiopurines. Biochem Pharmacol 28:445?446","journal-title":"Biochem Pharmacol"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/978-1-4757-0390-0_69","volume":"165B","author":"TJ Schouten","year":"1984","unstructured":"Schouten TJ, Abreu RA De, Bruyn CHMM de, Kleijn E van der, Oosterbaan MJM, Schretlen EDAM, Vaan GAM de (1984) 6-Mercaptopurine: pharmacokinetics in animals and preliminary results in children. Adv Exp Med Biol 165B:367?370","journal-title":"Adv Exp Med Biol"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3109\/08880018509141213","volume":"2","author":"TJ Schouten","year":"1985","unstructured":"Schouten TJ, Abreu RA De, Bruyn CHMM de, Kleijn E van der, Oosterbaan MJM, Schretlen EDAM, Vaan GAM de (1985) 6-Mercaptopurine: oral administration and i.v. bolus injections in dogs. Eur Paediatr Haematol Oncol 2:93?98","journal-title":"Eur Paediatr Haematol Oncol"},{"key":"CR20","first-page":"113","volume":"3","author":"TJ Schouten","year":"1986","unstructured":"Schouten TJ, Abreu RA De, Schretlen EDAM, Vaan GAM de, Kleijn E van der (1986) 6-Mercaptopurine: total body autoradiograms and plasma concentration-time curves of 6MP and metabolites from Marmoset monkeys. Ped Hematol Oucol 3: 113?122","journal-title":"Ped Hematol Oucol"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1016\/0006-2952(82)90096-X","volume":"31","author":"JD Strobel-Stevens","year":"1982","unstructured":"Strobel-Stevens JD, Dareer SM El, Trader MW, Hill DL (1982) Some biochemical characteristics of L1210 cell lines resistant to 6-mercaptopurine and 6-thioguanine and with increased sensitivity to methotrexate. Biochem Pharmacol 31:3133?3137","journal-title":"Biochem Pharmacol"},{"key":"CR22","first-page":"411","volume":"102","author":"MHN Tattersall","year":"1983","unstructured":"Tattersall MHN, Slowiaczek P, Fazio A De (1983) Regional variation in human extracellular purine levels. J Lab Clin Med 102:411?420","journal-title":"J Lab Clin Med"},{"key":"CR23","first-page":"733","volume":"34","author":"DM Tidd","year":"1974","unstructured":"Tidd DM, Paterson ARP (1974a) Distinction between inhibition of purine nucleotide synthesis and the delayed cytotoxic reaction of 6-mercaptopurine. Cancer Res 34:733?737","journal-title":"Cancer Res"},{"key":"CR24","first-page":"738","volume":"34","author":"DM Tidd","year":"1974","unstructured":"Tidd DM, Paterson ARP (1974b) A biochemical mechanism for the delayed cytotoxic reaction of 6-mercaptopurine. Cancer Res 34:738?746","journal-title":"Cancer Res"},{"key":"CR25","first-page":"317","volume":"32","author":"DM Tidd","year":"1972","unstructured":"Tidd DM, Kim SC, Horakova K, Moriwaki A, Paterson ARP (1972) A delayed cytotoxic reaction for 6-mercaptopurine. Cancer Res 32:317?322","journal-title":"Cancer Res"},{"key":"CR26","volume-title":"Fundamentals of clinical pharmacokinetics","author":"JG Wagner","year":"1975","unstructured":"Wagner JG (1975) Fundamentals of clinical pharmacokinetics, 1st edn. Drug Intelligence Publications, Hamilton, Ill, USA","edition":"1st edn."},{"key":"CR27","first-page":"1458","volume":"40","author":"LL Wotring","year":"1980","unstructured":"Wotring LL, Roti Roti JL (1980) Thioguanine-induced S and G2 blocks and their significance to the mechanism of cytotoxicity. Cancer Res 40:1458?1462","journal-title":"Cancer Res"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJM198304283081705","volume":"308","author":"S Zimm","year":"1983","unstructured":"Zimm S, Collins JM, Riccardi R, O'Neill D, Narang PK, Chabner B, Poplack DG (1983) Variable bioavailability of oral mercaptopurine. Is maintenance chemotherapy in acute lymphoblastic leukemia being optimally delivered? N Engl J Med 308:1005?1009","journal-title":"N Engl J Med"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1016\/0006-2952(84)90026-1","volume":"24","author":"S Zimm","year":"1984","unstructured":"Zimm S, Grygiel JJ, Strong JM, Monks TJ, Poplack DG (1984) Identification of 6-mercaptopurine riboside in patients receiving 6-mercaptopurine as a prolonged intravenous infusion. Biochem Pharmacol 24:4089?4092","journal-title":"Biochem Pharmacol"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00394941.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00394941\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00394941","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T21:36:04Z","timestamp":1554327364000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00394941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1986,7]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1986,7]]}},"alternative-id":["BF00394941"],"URL":"https:\/\/doi.org\/10.1007\/bf00394941","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[1986,7]]}}}